These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19456279)

  • 1. Selective MMP-12 inhibitors: WO-2008057254.
    Norman P
    Expert Opin Ther Pat; 2009 Jul; 19(7):1029-34. PubMed ID: 19456279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).
    Li W; Li J; Wu Y; Wu J; Hotchandani R; Cunningham K; McFadyen I; Bard J; Morgan P; Schlerman F; Xu X; Tam S; Goldman SJ; Williams C; Sypek J; Mansour TS
    J Med Chem; 2009 Apr; 52(7):1799-802. PubMed ID: 19278250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of potent and selective matrix metalloprotease 12 inhibitors for the potential treatment of chronic obstructive pulmonary disease (COPD).
    Wu Y; Li J; Wu J; Morgan P; Xu X; Rancati F; Vallese S; Raveglia L; Hotchandani R; Fuller N; Bard J; Cunningham K; Fish S; Krykbaev R; Tam S; Goldman SJ; Williams C; Mansour TS; Saiah E; Sypek J; Li W
    Bioorg Med Chem Lett; 2012 Jan; 22(1):138-43. PubMed ID: 22153340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.
    Holmes IP; Gaines S; Watson SP; Lorthioir O; Walker A; Baddeley SJ; Herbert S; Egan D; Convery MA; Singh OM; Gross JW; Strelow JM; Smith RH; Amour AJ; Brown D; Martin SL
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5760-3. PubMed ID: 19703773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.
    Nuti E; Panelli L; Casalini F; Avramova SI; Orlandini E; Santamaria S; Nencetti S; Tuccinardi T; Martinelli A; Cercignani G; D'Amelio N; Maiocchi A; Uggeri F; Rossello A
    J Med Chem; 2009 Oct; 52(20):6347-61. PubMed ID: 19775099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and SAR of highly selective MMP-13 inhibitors.
    Li J; Rush TS; Li W; DeVincentis D; Du X; Hu Y; Thomason JR; Xiang JS; Skotnicki JS; Tam S; Cunningham KM; Chockalingam PS; Morris EA; Levin JI
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4961-6. PubMed ID: 16153831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metalloprotease inhibitors as anti-inflammatory agents: an evolving target?
    Whelan CJ
    Curr Opin Investig Drugs; 2004 May; 5(5):511-6. PubMed ID: 15202724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alkyl diphenylacetyl, 9H-xanthene- and 9H-thioxanthene-carbonyl carbamates as positive allosteric modulators of mGlu1 receptors.
    Wichmann J; Bleicher K; Vieira E; Woltering T; Knoflach F; Mutel V
    Farmaco; 2002 Dec; 57(12):989-92. PubMed ID: 12564473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which of three structures is AZD-3199? WO-2008104790, WO-2008096112 and WO-2008096119.
    Norman P
    Expert Opin Ther Pat; 2009 Aug; 19(8):1157-63. PubMed ID: 19563269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage metalloelastase (MMP-12) as a target for inflammatory respiratory diseases.
    Lagente V; Le Quement C; Boichot E
    Expert Opin Ther Targets; 2009 Mar; 13(3):287-95. PubMed ID: 19236151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.
    Baragi VM; Becher G; Bendele AM; Biesinger R; Bluhm H; Boer J; Deng H; Dodd R; Essers M; Feuerstein T; Gallagher BM; Gege C; Hochgürtel M; Hofmann M; Jaworski A; Jin L; Kiely A; Korniski B; Kroth H; Nix D; Nolte B; Piecha D; Powers TS; Richter F; Schneider M; Steeneck C; Sucholeiki I; Taveras A; Timmermann A; Van Veldhuizen J; Weik J; Wu X; Xia B
    Arthritis Rheum; 2009 Jul; 60(7):2008-18. PubMed ID: 19565489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.
    Li W; Li J; Wu Y; Rancati F; Vallese S; Raveglia L; Wu J; Hotchandani R; Fuller N; Cunningham K; Morgan P; Fish S; Krykbaev R; Xu X; Tam S; Goldman SJ; Abraham W; Williams C; Sypek J; Mansour TS
    J Med Chem; 2009 Sep; 52(17):5408-19. PubMed ID: 19725580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2,3-Dihydro-1,3-dioxo-1H-isoindole-5-carboxylic acid derivatives: a novel class of small molecule heparanase inhibitors.
    Courtney SM; Hay PA; Buck RT; Colville CS; Porter DW; Scopes DI; Pollard FC; Page MJ; Bennett JM; Hircock ML; McKenzie EA; Stubberfield CR; Turner PR
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3269-73. PubMed ID: 15149688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies.
    Bora-Tatar G; Dayangaç-Erden D; Demir AS; Dalkara S; Yelekçi K; Erdem-Yurter H
    Bioorg Med Chem; 2009 Jul; 17(14):5219-28. PubMed ID: 19520580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revisiting matrix metalloproteinase 12: its role in pathophysiology of asthma and related pulmonary diseases.
    Abd-Elaziz K; Jesenak M; Vasakova M; Diamant Z
    Curr Opin Pulm Med; 2021 Jan; 27(1):54-60. PubMed ID: 33065600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cilomilast GlaxoSmithKline.
    Brown WM
    Curr Opin Investig Drugs; 2005 May; 6(5):545-58. PubMed ID: 15912970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms of cytochrome p450 and matrix metalloproteinase in chronic obstructive pulmonary disease.
    Cheng SL; Yu CJ; Yang PC
    Biochem Genet; 2009 Aug; 47(7-8):591-601. PubMed ID: 19507017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diphenylmethylene hydroxamic acids as selective class IIa histone deacetylase inhibitors.
    Tessier P; Smil DV; Wahhab A; Leit S; Rahil J; Li Z; Déziel R; Besterman JM
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5684-8. PubMed ID: 19699639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The overlap syndrome: obstructive sleep apnea and chronic obstructive pulmonary disease].
    Shteinberg M; Weiler-Ravel D; Adir Y
    Harefuah; 2009 May; 148(5):333-6, 348. PubMed ID: 19630366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
    Gordon E; Lazarus SC
    J Allergy Clin Immunol; 2009 Nov; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.